Phenotypically different osteoclasts may be generated from different subsets of precursors. To what extent the formation of these osteoclasts is influenced or mediated by the inflammatory cytokine TNF-α, is unknown and was investigated in this study. The osteoclast precursors early blasts (CD31 blasts. This inhibitory effect could not be prevented by other cytokines such as IL-1β or IL-6. When monocytes were pre-cultured with M-CSF and RANKL followed by exposure to TNF-α, a stimulatory effect was found. TNF-α also stimulated monocytes' osteoclastogenesis when the cells were seeded on bone. Gene expression analysis showed that when TNF-α was added to monocytes cultured on plastic, RANK, NFATc1, and TRAcP were significantly down-regulated while TNF-αR1 and TNF-αR2
Phenotypically different osteoclasts may be generated from different subsets of precursors. To what extent the formation of these osteoclasts is influenced or mediated by the inflammatory cytokine TNF-α, is unknown and was investigated in this study. The osteoclast precursors early blasts (CD31 blasts. This inhibitory effect could not be prevented by other cytokines such as IL-1β or IL-6. When monocytes were pre-cultured with M-CSF and RANKL followed by exposure to TNF-α, a stimulatory effect was found. TNF-α also stimulated monocytes' osteoclastogenesis when the cells were seeded on bone. Gene expression analysis
showed that when TNF-α was added to monocytes cultured on plastic, RANK, NFATc1, and TRAcP were significantly down-regulated while TNF-αR1 and TNF-αR2
were up-regulated. FACS analysis showed a decreased uptake of fluorescently labeled RANKL in monocyte cultures in the presence of TNF-α, indicating an altered ratio of bound-RANK/unbound-RANK. Our findings suggest a diverse role of TNF-α on monocytes' osteoclastogenesis: it affects the RANK-signaling pathway therefore inhibits osteoclastogenesis when added at the onset of monocyte culturing. This can be prevented when monocytes were pre-cultured with M-CSF and RANKL, which ensures the binding of RANKL to RANK. This could be a mechanism to prevent unfavorable monocyte-derived osteoclast formation away from the bone.
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| INTRODUCTION
An increasing number of people throughout the world suffer from inflammation-related bone diseases, such as rheumatoid arthritis and periodontitis. Excessive release of inflammatory cytokines is associated with chronic inflammation and bone destruction. Tumor necrosis factor α (TNF-Osteoclasts, the multinucleated bone-resorbing cells, are crucial in bone diseases with excessive bone loss. Severe bone destruction occurs when the equilibrium of osteoclast and osteoblast activity is disturbed. Osteoclasts arise from monocytic precursors under the influence of M-CSF and RANKL. Next to these cytokines, TNF-α has been shown to stimulate osteoclast generation and bone resorption both in vitro (Thomson, Mundy, & Chambers, 1987) and in vivo (König, Mühlbauer, & Fleisch, 1988) .
TNF-α-and RANKL-induced osteoclastogenesis share a similar intracellular pathway (Kitaura et al., 2013) . They both induce osteoclast differentiation by activating c-fos and NFATc1
signaling (Yamashita et al., 2007) . TNF-α induces TRAF2, which can further stimulate RANK associated TRAF6-induced osteoclastogenesis (Kitaura et al., 2013) .
TNF-α recognizes two receptors both in human and in mouse, TNF-R1
(p55) and TNF-R2 (p75) (Vandenabeele, Declercq, Beyaert, & Fiers, 1995) .
TNF-R1 promotes osteoclastogenesis (Abu-Amer et al., 2000) and the stimulatory effect of TNF-α can be completely prevented by anti-p55
antibody. Blocking of TNF-R2 with anti-p75 antibody only partially inhibits osteoclastogenesis (Azuma, Kaji, Katogi, Takeshita, & Kudo, 2000; Kobayashi et al., 2000) . TNF-α accelerates RANKL-induced osteoclastogenesis via coupling to TNF-α R1 (Zhang, Heulsmann, Tondravi, Mukherjee, & Abu-Amer, 2001 ). Although some studies showed that TNF-α is RANK/RANKL-dependent (Lam et al., 2000) , others showed that TNF-α induced osteoclastogenesis is independent of RANK/RANKL (Kim et al., 2005; Kobayashi et al., 2000) .
Cells that can differentiate into osteoclasts are widely distributed in the body, including bone marrow precursors, peritoneal macrophages, splenocytes, peripheral blood-borne monocytes, and dendritic cells (Marks & Walker, 1981; Quinn, Sabokbar, & Athanasou, 1996; Rivollier et al., 2004; Scheven, Visser, & Nijweide, 1986) . Several studies have shown that osteoclast precursors isolated from different skeletal sites are not always identical in terms of osteoclastogenesis De Souza Faloni et al., 2011; Everts, de Vries, & Helfrich, 2009 ). Even within the same site, different precursor subsets were shown to differ in their capacity to form osteoclasts De Vries, Schoenmaker, Hooibrink, Leenen, & Everts, 2009; De Vries et al., 2015; Jacquin, Gran, Lee, Lorenzo, & Aguila, 2006; Sprangers, Schoenmaker, Cao, Everts, & de Vries, 2016) .
One of the main sites where osteoclast precursors reside is the bone marrow. In the marrow of mice three monocytic precursors can be recognized: early blasts (CD31 hi Ly-6C − ), myeloid blasts (CD31 + Ly-6C + ), and monocytes (CD31 − Ly-6C hi ) (Nikolic, de Bruijn, Lutz, & Leenen, 2003) . Each subset has the potential to differentiate into osteoclasts .
Recently, studies have reported that these three precursor subsets respond differently to the growth factor M-CSF (De Vries et al., 2015) and the cytokine IL-1β .
Myeloid blasts were found to respond the fastest to M-CSF and RANKL ) and early blasts was the only population that proliferated under the influence of IL-1β . How these three myeloid lineage-osteoclast precursor subsets respond to another crucial inflammatory cytokine, TNF-α, is unknown and is the topic of the present study. We investigated the effect of TNF-α on the osteoclasto- 
| Immunofluorescence labeling and cell sorting
Bone marrow cells were labeled with CD31 and Ly-6C following the labeling procedure described previously 
| Cell culturing
The three sorted subsets, early blasts, myeloid blasts, and monocytes were seeded in 96-well plastic plates (CELLSTAR®;
Greiner Bio-One, Monroe, NC) at a density of 1.5 × 10 4 cells/well in 150 μl culture medium with different conditions: with or without 30 ng/ml M-CSF (R&D Systems, Minneapolis, MN), with or without 20 ng/ml RANKL (RANKL-TEC, R&D systems), with 0, 10, or 100 ng/ml TNF-α (R&D Systems), with or without 10 ng/ml IL-1β
(Sigma-Aldrich), with or without 10 ng/ml IL-6 (Sigma-Aldrich).
Cells were cultured on plastic or on 650 μm-thick bone slices and culture media were refreshed every 3 days. After 5 days the cultures on plastic plates were stopped by fixation in 4% PBSbuffered formaldehyde for TRAcP analysis, or lysed in RNA lysis buffer (Qiagen, Hilden, Germany) at day 0, 3, and 5 for RNA isolation. Bone slices were stored in water after 6 days of culture and culture media was collected for CTX assay. 
| Quantitative RT-PCR
The procedure of RT-PCR was described in detail in a previous paper . Quantitative expression of TRAcP, NFATc1, RANK, TNF-αR1, and TNF-αR2 were determined. Primers were designed using Primer Express 3.0. The results were shown as fold increased, normalized by the same gene expression at day 0.
| FACS analysis
After the isolation of myeloid blasts and monocytes, these precursor cells were cultured with M-CSF and RANKL, with or without 10 ng/ml TNF-α for 3 days. Subsequently, precursor cells were collected using FIGURE 1 Flow cytometric gating of murine bone marrow. (a) Three osteoclast precursor subsets, early blasts, myeloid blasts, and monocytes were sorted after labeling CD31 and Ly-6C. (b) Percentage of each population. In total six populations could be distinguished: early blasts (1.0%), myeloid blasts (6.0%), monocytes (4.0%), lymphocytes (23.3%), erythroid blasts (28.4%), and granulocytes (23.1%) FIGURE 2 Effect of TNF-α on osteoclastogenesis by different osteoclast precursors on plastic. (a-c) Early blasts (1st row), myeloid blasts (2nd row), and monocytes (3rd row) were cultured under three different culture conditions: (a) condition 1 (control), with 30 ng/ml M-CSF and 20 ng/ml RANKL for 5 days; (b) condition 2, with 30 ng/ml M-CSF, 20 ng/ml RANKL and 10 ng/ml TNF-α for 5 days; (c) condition 3, first cultured with 30 ng/ml M-CSF and 20 ng/ml RANKL for 3 days, then cells were further cultured with 30 ng/ml M-CSF, 20 ng/ml RANKL and 10 ng/ml TNF-α for 2 days. Cells were stained for TRAcP activity and nuclei were counterstained by DAPI. Osteoclasts were recognized as TRAcP + multinucleated cells (purple) and nuclei were visualized as blue. Note the absence of any multinucleated cells in monocyte cultures in condition 2. Scale bar = 100 μm. (d-f). Total number of TRAcP + multinucleated cells (>2 nuclei), number of small osteoclasts (3-10 nuclei), and number of large osteoclasts (>10 nuclei) generated by the three subsets. White column: cells cultured with 30 ng/ml M-CSF and 20 ng/ml RANKL for 5 days (condition 1). Black column: cells cultured with 30 ng/ml M-CSF, 20 ng/ml RANKL, and 10 ng/ml TNF-α for 5 days (condition 2). (g-i). Total number of TRAcP + multinucleated cells (>2 nuclei), number of small osteoclasts (3-10 nuclei), and number of large osteoclasts (>10 nuclei) generated by the three subsets with M-CSF and RANKL priming. White column: cells cultured with 30 ng/ml M-CSF and 20 ng/ml RANKL for 5 days (condition 1). Black column: cells first cultured with 30 ng/ml M-CSF and 20 ng/ml RANKL for 3 days, then 10 ng/ml TNF-α was added and cells were further cultured with M-CSF, RANKL, and TNF-α for 2 more days (condition 3). (n = 6, *p < 0.05, **p < 0.01, ***p < 0.001) Cells were subsequently fixed with 1% formaldehyde and analyzed by 
| Statistical analysis
All data were analyzed from six mice (n = 6) and GraphPad Prism (version 6.00; GraphPad Software, LaJolla, CA) was used for the statistical analysis. One-way ANOVA followed by Tukey-Kramer's multiple comparison was used for multiple comparisons, and t-test was used for two comparisons. Data are displayed as mean ± SD and p < 0.05 was considered as significant difference.
3 | RESULTS 3.1 | TNF-α prevents monocyte-derived osteoclastogenesis on plastic; an effect that was abolished with M-CSF and RANKL priming 
FIGURE 4
The inhibitory effect of TNF-α on osteoclastogenesis was abolished by seeding monocytes on bone. Micrographs of cultures on bone of the three subsets. (a) condition 1 (control) with 30 ng/ml M-CSF and 20 ng/ml RANKL for 6 days; (b) condition 2, with 30 ng/ml M-CSF and 20 ng/ml RANKL with 10 ng/ml TNF-α for 6 days; and (c) condition 3, with 30 ng/ml M-CSF and 20 ng/ml RANKL first cultured for 3 days followed by 3 days culture with 30 ng/ml M-CSF, 20 ng/ml RANKL, and 10 ng/ml TNF-α. Scale bar = 100 μm. 3.2 | IL-1β and IL-6 were not able to prevent the inhibitory effect of TNF-α on monocytes' osteoclastogenesis
Next to TNF-α also two other inflammatory cytokines, IL-1β and IL-6, have been shown to stimulate osteoclastogenesis. We wondered whether IL-1β or IL-6 might influence the effect of TNF-α as shown above. In the presence of IL-1β or IL-6, high numbers of TRAcP + cells
FIGURE 5
Bone resorption under the influence of TNF-α. (a) Resorption visualized with Coomassie brilliant blue staining, in cultures with 30 ng/ml M-CSF and 20 ng/ml RANKL (control) for 6 days (condition 1); 30 ng/ml M-CSF and 20 ng/ml RANKL with 10 ng/ml TNF-α for 6 days (condition 2), and with 30 ng/ml M-CSF and 20 ng/ml RANKL first cultured for 3 days followed by 3 days culture with 30 ng/ml M-CSF, 20 ng/ml RANKL, and 10 ng/ml TNF-α (condition 3). (b-d) Percentage of bone resorbed by osteoclasts derived from early blasts, myeloid blasts, and monocytes. (e-f) Collagen fragment release from early blast cultures, myeloid blast cultures, and monocyte cultures measured with CTX assay after 6 days. Scale bar = 100 μm. (n = 6, *p < 0.05, **p < 0.01, ***p < 0.001)
were present in monocyte cultures (Figure 3a ). IL-6 alone or a combination of IL-6 and IL-1β resulted in a significantly higher number of osteoclasts compared to the control cultures (with M-CSF and RANKL alone) (Figure 3b ). Monocytes proved to be insensitive to IL-1β: no increased osteoclastogenesis was observed here; a finding in line with previous findings . However, whenever TNF-α was added at the onset of the monocyte cultures, osteoclastogenesis was completely inhibited (see conditions 2-6 in Figure 3 ). This was apparent both in the absence and in the presence of IL-1β and/or IL-6, indicating that the latter two cytokines were not able to prevent the inhibitory effect of TNF-α. In the presence of TNF-α most cells proved to be TRAcP-negative (Figure 3a , conditions 2-6). This inhibitory effect was not found with early blasts and myeloid blasts 
| TNF-α stimulated bone resorption
To determine the level of bone resorption, the bone slices were stained with Coomassie brilliant blue to visualize pit formation, and the culture media were analyzed for the level of CTX ( Figure 5 ). All bone slices showed resorption pits, indicating that under all conditions active osteoclasts were generated (Figure 5a ). The level of resorbed bone was assessed by analyzing the surface area of the pits in relation to the entire bone surface and was expressed as percentage of resorption (Figure 5b-d) . The data indicated that TNF-α stimulated resorption by osteoclasts formed by early blasts (Figure 5b ). Osteoclasts derived from monocytes showed the highest resorption when TNF-α was added after M-CSF and RANKL priming (Figure 5d ). Osteoclasts generated from myeloid blasts, showed a significantly higher resorption area in both conditions with TNF-α (Figure 5c ). The CTX data were in line with the resorption data and confirmed the stimulatory effect of TNF-α on bone resorption (Figure 5e-g ).
| TNF-α down-regulated osteoclast-related genes and up-regulated TNF-α receptors by monocytes on plastic
In seen on the right hand side of the graph (Figure 7b ). In the control group, the RANKL high sub-population was almost two times higher (66 ± 6%) than the RANKL low sub-population (34 ± 6%). In the group with TNF-α, this pattern was reversed. The percentage of RANKL high sub-population was much lower (37 ± 4%) than that of RANKL low subpopulation (63 ± 4%). Thus, TNF-α decreased the binding of fluorescently labeled RANKL; an effect particularly apparent in monocytes.
| DISCUSSION
In the present study we found that TNF-α had the capacity to prevent osteoclastogenesis of one specific precursor subset: bone marrow derived 
| A model for TNF-α on monocytes' osteoclastogenesis
The most intriguing finding of this study was the inhibitory effect of TNF-α on osteoclastogenesis of monocytes when cultured on plastic, whereas it increased osteoclastogenesis when the cells were first exposed to M-CSF and RANKL or, alternatively, seeded on bone. Under the former (on plastic) condition we found a decreased mRNA level of RANK by the monocytes,
and an increased population of monocytes with a lower level of fluorescently labeled RANKL. The protein level of RANK proved to be unaffected. Thus, it is likely that the RANKL/RANK signaling pathway was affected. Our findings indicate that TNF-α can express both inhibitory and stimulatory effects on monocytes' osteoclastogenesis. A hypothetical model that offers an explanation for our findings is shown in Figure 8 .
When monocytes are cultured with M-CSF and RANKL, RANKL will bind to RANK expressed on the membrane of monocytes, leading to upregulation of osteoclast-related genes, such as NFATc1. This will result in osteoclast differentiation (Figure 8a ). However, when TNF-α is present from the onset together with M-CSF and RANKL, it appears that RANK signaling is not well triggered (Figure 8b ). This results in a down-regulated gene 
| Relationship between TNF-α and RANK/RANKL
Clearly the relationship between TNF-α and RANKL in osteoclastogenesis is complex. Kobayashi et al. (2000) showed that the stimulatory effect of TNF-α on osteoclastogenesis is M-CSF-dependent rather than RANK/RANKL-dependent. Studies by Kim et al. (2005) demonstrated that TNF-α together with TGF-β stimulates osteoclastogenesis independent of the RANKL-RANK axis. However, Zhang et al. (2001) showed that TNF-α synergistically cooperates with RANK/RANKL-induced osteoclastogenesis and an overlapping signaling pathway of RANKL and TNF-α was proposed. Others stated that RANKL-and TNF-induced osteoclastogenesis share a similar intracellular signaling pathway, including c-fos and NFATc1 (Yamashita et al., 2007) . Lam et al. (2000) showed that a basal level of RANKL is necessary for TNF-α induced osteoclast formation: TNF-α alone, or with M-CSF, at any concentration, failed to stimulate osteoclast differentiation. Depending on the time point, TNF-α proved to inhibit or potentiate RANKL-mediated osteoclastogenesis. TNF-α inhibited osteoclastogenesis by purified myeloid cell cultures when it was present with RANKL at the onset of the culture, but the cytokine stimulated osteoclastogenesis when it was added 2-4 days after RANKL priming (Lam et al., 2000) . This coincides with the present study which shows adding TNF-α at a later time point after RANKL and M-CSF priming stimulates monocyte-derived osteoclast formation.
In order to prove that TNF-α is closely associated with ). An increased level of IL-1 has been shown to stimulate TNF-induced osteoclastogenesis (Wei, Kitaura, Zhou, Ross, & Teitelbaum, 2005) . In our study, exposure to IL-1β could not overcome the inhibitory effect found in monocytes on plastic (Figure 3 ).
Therefore, key molecules of bone, or released by osteoclasts that were grown on bone, remain to be elucidated.
When we compare the number of osteoclasts per surface area when cells were cultured either on bone slices or on plastic plates, the number of osteoclasts formed on the bone slices were shown to be significantly higher than the number formed on plastic ( Figure S1g ). This is in line with our previous study in which we showed higher numbers of TRAcP + multinucleated cells on bone than on plastic . Of considerable interest was the finding that cells present on plastic next to the bone slices did form osteoclasts. This counts also for monocyte cultures (Figure 4f in monocyte panel). Since monocytes seeded on plastic in the absence of bone were inhibited in their capacity to generate osteoclasts, this finding suggests the presence of one or more compounds prevented the TNF-α induced inhibition. Such compounds could be released either by the monocytes due to their interaction with the bone surface or by the bone slice itself. Bone tissue, as a natural matrix for osteoclast formation, was shown to overcome osteoclastogenesis-insensitivity of certain osteoclast precursor subsets (De Vries et al., 2015) . It was demonstrated that expression of NFATc1, being a key molecule in the regulation of osteoclastogenesis, was stimulated on bone. Osteoclast precursors are likely to interact with a number of stimulatory components elicited FIGURE 9 Physiological explanation of the effect of TNF-α on monocytes' osteoclastogenesis in vivo. TNF-α inhibits monocytes' osteoclastogenesis at sites at a distance from bone. When monocytes interact with the bone surface, TNF-α stimulates RANKL-induced osteoclast formation from the bone matrix, for example transforming growth factor-β (Mundy & Bonewald, 1990; Zwerina et al., 2004 ) and proteins such as osteopontin and bone sialoprotein (Fisher, Torchia, Fohr, Young, & Fedarko, 2001; Qin, Baba, & Butler, 2004 , Yao et al., 2008 . Molecules such as osteoclast-associated receptor (OSCAR) expressed by preosteoclasts, were shown as a collagen receptor that stimulates osteoclastogenesis (Barrow et al., 2011) . monocytes were shown to be sensitive to IL-1β . In line with the inhibitory effect of TNF-α which was only found in monocyte cultures in this study, Hayashi et al. (2003) showed that splenic osteoclastogenesis was completely inhibited by TNF-α; an effect not found with bone marrow cells. Since the spleen stores about half of the number of monocytes present in the body (Swirski et al., 2009) , our finding of the inhibitory effect of TNF-α on bone marrow monocytes suggests a similarity between spleen monocytes and those present in the marrow. Comparing the three myeloid precursor subsets, monocytes showed a different distribution of the receptors of TNF-α: monocytes have a significantly higher mRNA level of TNF-αR1 and TNF-αR2 on day 0 compared to myeloid blasts and early blasts (Figure S3l, m) . This suggests that monocytes are the cell type more sensitive to TNF-α, and this sensitivity has a close relationship to RANKL exposure.
Is there a physiological explanation for a cell type that becomes osteoclastogenesis-insensitive to a cytokine like TNF-α? Under pathological conditions the cytokine is present throughout the body and this could in theory result in the formation of osteoclasts anywhere in the body. After all TNF-α as well as the monocytes are present at many different sites, and RANKL is also present in serum (Findlay & Atkins, 2011) . We propose that monocytes, not in the vicinity of bone, are insensitive to the cytokine, therefore, osteoclast formation does not occur at these sites away from the bone (Figure 9 ). When these monocytes attach to the bone surface, they become sensitive to TNF-α and osteoclastogenesis is stimulated. We hypothesize that such a versatile role of the cytokine is meaningful in modulating the process of osteoclastogenesis. 
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